Optimal
>60 L/min for low to medium-high resistance DPIs
>30 L/min for high-resistance DPIs
Impaired
Cognitive: Dementia, intellectual disabilities, memory loss, trouble completing tasks, and/or difficulty following instructions
Manual: Impaired fine motor activities, tremor, reduced handgrip strength, arthritis
Recommendations:
Suboptimal <60 L/min for low to medium-high resistance DPIs
<30 L/min for high-resistance DPIs
DPI
SMI
Suboptimal
Optimal
Peak Inspiratory Flow
IMPAIRED
NORMAL
Cognitive Function and/or Manual Dexterity
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
pMDI + Valved Holding Chamber
Recommendations:
Select an option above by clicking on it
PARI COMPACT2 with PARI LC SPRINT COMPACT
pMDI + Valved Holding Chamber
Recommendations:
Select an option above by clicking on it
PARICOMPACT2 with PARI LC SPRINT COMPACT
pMDI + Valved Holding Chamber
Recommendations:
SMI
DPI
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Recommendations:
Select an option above by clicking on it
Select an option above by clicking on it
Select an option above by clicking on it
SMI
pMDI
Recommendations:
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
Select an option above by clicking on it
pMDI
Use in COPD patients who feel congested and have sticky mucus, or have mucus plugs present on CT scan. Nebulised saline thins sticky mucus and helps patients to clear their airways. GOLD guideline recommends oscillating PEP therapy for mucus mobilisation. Mucus clearance treatments may improve symptoms and quality of life in COPD patients.
Disclaimer: The proposals of the device are based on the recommendations of international guidelines. However, the interactive Device Selection Tool does not replace the expertise of the treating healthcare professional.
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
Select the optimal device for inhalation therapy for your patient by moving your mouse to the area of the chart that best describes your patient's level of cognitive function and/or manual dexterity, as well as their peak inspiratory flow. Click on the ⓘ fields for some guidance. Once you have made your selection, click on the relevant device for more details.
PARI Interactive Device Selection Tool for COPD
PARICOMPACT2 with PARI LC SPRINT COMPACT
PARICOMPACT2 with PARI LC SPRINT COMPACT
Find out how PARI products can help COPD patients – COPD-PARI
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
INTERNATIONAL
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider A VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs • Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
Click for a demonstration of the PARI interactive device selection tool
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider A VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs • Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Consider A VHC in patients with poor hand-breath coordination and those using corticosteroids in pMDIs • Advantage: Reduced dysphonia, reduced oropharyngeal deposition.
• Disadvantage: Higher bulkiness, higher maintenance requirements compared to pMDI alone.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
Click for a demonstration of the PARI interactive device selection tool
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Use in COPD patients who feel congested and have sticky mucus, or have mucus plugs present on CT scan. Nebulised saline thins sticky mucus and helps patients to clear their airways. GOLD guideline recommends oscillating PEP therapy for mucus mobilisation. Mucus clearance treatments may improve symptoms and quality of life in COPD patients.
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak. inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Recommendations:
Suboptimal
Optimal
Peak Inspiratory Flow
IMPAIRED
NORMAL
Cognitive Function and/or Manual Dexterity
Optimal
>60 L/min for low to medium-high resistance DPIs
>30 L/min for high-resistance DPIs
Suboptimal <60 L/min for low to medium-high resistance DPIs
<30 L/min for high-resistance DPIs
Impaired
Cognitive: Dementia, intellectual disabilities, memory loss, trouble completing tasks, and/or difficulty following instructions
Manual: Impaired fine motor activities, tremor, reduced handgrip strength, arthritis
UK
UK
INTERNATIONAL
Click for a demonstration of the PARI interactive device selection tool
通过点击选择上面的选项
是
是
肺分泌物
如果存在肺分泌物，请点击“是” 如需了解更多信息，请点击 ⓘ
雾化器，例如 PARI BOY Pro 与 PARI LC SPRINT 结合使用
软雾吸入器(SMI)
加压定量吸入器(pMDI)
胸部充血、黏稠痰液、痰液过多、CT 扫描显示黏液栓塞
建议
通过点击选择上面的选项
是
是
肺分泌物
如果存在肺分泌物，请点击“是” 如需了解更多信息，请点击 ⓘ
雾化器，例如 PARI BOY Pro 与 PARI LC SPRINT 结合使用
软雾吸入器(SMI)
干粉吸入器(DPI)
加压定量吸入器(pMDI)
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
胸部充血、黏稠痰液、痰液过多、CT 扫描显示黏液栓塞
建议：
通过点击选择上面的选项
是
是
肺分泌物
如果存在肺分泌物，请点击“是” 如需了解更多信息，请点击 ⓘ
胸部充血、黏稠痰液、痰液过多、CT 扫描显示黏液栓塞
建议：
通过点击选择上面的选项
是
是
肺分泌物
如果存在肺分泌物，请点击“是” 如需了解更多信息，请点击 ⓘ
雾化器，例如 PARI BOY Pro 与 PARI LC SPRINT 结合使用
•急性加重慢性阻塞性肺病(AECOPD)且峰值吸气流速未达标 (sPIF)的患者可从雾化治疗中获益 • 根据《GOLD 2025报告》，若患者无法正确使用定量吸入器（带或不带储雾罐）、干粉吸入器或软雾吸入器，或患者更倾向于使用雾化器而非其他手持设备，应考虑采用雾化治疗 • 长效 β2 受体激动剂 (LABA)、长效毒蕈碱拮抗剂 (LAMA)、吸入性糖皮质激素 (ICS）或双磷酸二酯酶抑制剂（PDE3/PDE4）溶液可用时，应考虑维持性雾化治疗。
加压定量吸入器(pMDI) + 单向阀储雾罐 例如：PARI Health 储雾罐
了解 PARI 产品如何帮助慢性阻塞性肺病患者 - 慢性阻塞性肺病 - PARI
• 对于有充血、黏稠痰液或黏液栓的患者，考虑使用雾化盐水和/或 PARI PEP 设备。 • 有效的黏液管理可能会改善慢性阻塞性肺病患者的症状和生活质量。
雾化盐水 | PARI PEP S 系统
胸部充血、黏稠痰液、痰液过多、CT 扫描显示黏液栓塞
建议：
通过点击选择上面的选项
是
是
肺分泌物
如果存在肺分泌物，请点击“是” 如需了解更多信息，请点击 ⓘ
胸部充血、黏稠痰液、痰液过多、CT 扫描显示黏液栓塞
加压定量吸入器(pMDI) + 单向阀储雾罐 例如：PARI Health 储雾罐
建议：
通过点击选择上面的选项
是
是
肺分泌物
如果存在肺分泌物，请点击“是” 如需了解更多信息，请点击 ⓘ
胸部充血、黏稠痰液、痰液过多、CT 扫描显示黏液栓塞
软雾吸入器(SMI)
SMI：适用于认知和手部功能正常的患者，应指导患者“缓慢平稳地吸气”。更多信息请查阅制造商说明。 优点：便携，通常可报销。 缺点：本装置无法使用吸入性糖皮质激素。
干粉吸入器(DPI)
DPI：适用于认知能力及手部操作能力正常且峰值吸气流速(PIF)达标的患者。患者操作指导应为：“用力快速吸气”。 更多信息请查阅制造商说明书。
优点：可使用多种药物及药物组合，设备便携，通常可报销。 缺点：患者需具备较高吸气流速才能分散药物。部分慢性阻塞性肺病患者的峰值吸气流速无法达标。
加压定量吸入器(pMDI)
pMDI：适用于认知能力及手部操作能力正常的患者。应指导患者：“缓慢平稳地吸入。”更多信息请查阅制造商说明书。
优点：可提供多种药物及药物组合，便携，通常可报销。 缺点：要求患者高度协调性，碳足迹相对较高。
建议：
不达标
达标
峰值
吸气流速
受损
正常
认知功能和/或手动灵活性
达标
>60 L/min，适用于低阻力到中高阻力干粉吸入器
>30 L/min，适用于高阻力干粉吸入器
不达标 <60 L/min，适用于低阻力到中高阻力干粉吸入器
<30 L/min，适用于高阻力干粉吸入器
受损
认知：痴呆、智力障碍、记忆丧失、完成任务困难和/或难以遵循指示
手动：精细运动能力活动受损、震颤、握力减弱、关节炎
UK
INTERNATIONAL
了解 PARI 产品如何帮助慢性阻塞性肺病患者 - 慢性阻塞性肺病 - PARI
• 对于有充血、黏稠痰液或黏液栓的患者，考虑使用雾化盐水和/或 PARI PEP 设备。 • 有效的黏液管理可能会改善慢性阻塞性肺病患者的症状和生活质量。
雾化盐水 | PARI PEP S 系统
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
了解 PARI 产品如何帮助慢性阻塞性肺病患者 - 慢性阻塞性肺病 - PARI
• 对于有充血、黏稠痰液或黏液栓的患者，考虑使用雾化盐水和/或 PARI PEP 设备。 • 有效的黏液管理可能会改善慢性阻塞性肺病患者的症状和生活质量。
雾化盐水 | PARI PEP S 系统
了解PARI产品如何帮助COPD患者 - PARI
• 根据《GOLD 2025报告》，若患者无法正确使用定量吸入器（pMDI），则建议采用单向阀储雾罐 。
• 对于手部与呼吸协调能力差的患者，以及使用含糖皮质激素pMDI的患者，应考虑采用单向阀储雾罐。
• 优点： 可减少声音嘶哑，降低药物在口咽部的沉积。
• 缺点： 与单独使用pMDI相比，体积更大，维护要求更高。
加压定量吸入器(pMDI) + 单向阀储雾罐 例如：PARI Health 储雾罐
雾化器，例如 PARI BOY Pro 与 PARI LC SPRINT 结合使用
中国
CHINA
CHINA
UK
INTERNATIONAL
中国
Click for a demonstration of the PARI interactive device selection tool
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Use in COPD patients who feel congested and have sticky mucus, or have mucus plugs present on CT scan. Nebulised saline thins sticky mucus and helps patients to clear their airways. GOLD guideline recommends oscillating PEP therapy for mucus mobilisation. Mucus clearance treatments may improve symptoms and quality of life in COPD patients.
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
PARI BOY Classic + PARI LC SPRINT
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a nebuliser should be considered if patients are unable to use a pMDI (with or without spacer), DPI or SMI correctly.
• Patients with acute exacerbation of COPD and suboptimal peak inspiratory flow may benefit from nebuliser therapy.
• Choosing an efficient nebuliser system is crucial – performance can vary significantly between devices.
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
pMDI + VORTEX
Find out how PARI products can help COPD patients – COPD-PARI
• According to the GOLD Report 2025, a VHC is recommended if the patient will not be able to use a pMDI correctly.
• Clinical study data demonstrate that the VORTEX significantly reduces the oropharyngeal steroid deposition.
• The VORTEX is proven effective regardless of patient’s inhaler technique or user capabilities.
Recommendations:
Select an option above by clicking on it
YES
YES
Lung Secretion
If lung secretion is present, click "yes" For more information click on ⓘ
Chest congestion, sticky mucus, mucus overproduction, mucus plugging on CT scan
SMI
SMI: Consider in patients with normal cognitive and manual capabilities, Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Portable, generally reimbursed. Disadvantage: Inhaled corticosteroids are not available in this device.
DPI
DPI: Consider in patients with normal cognitive and manual capabilities, and optimal PIF. Patient‘s instructions should be: "Inhale hard and fast.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: Patients require high inspiratory flow to de-aggregate medication. Some patients with COPD cannot achieve an optimal PIF.
pMDI
pMDI: Consider in patients with normal cognitive and manual capabilities. Patient‘s instructions should be: "Inhale slow and steady.“ Check manufacturer‘s instruction for more information.
Advantage: Broad range of drugs and drug combinations available, portable, generally reimbursed. Disadvantage: High degree of patient's coordination required, relatively high carbon footprint.
Recommendations:
Suboptimal
Optimal
Peak Inspiratory Flow
IMPAIRED
NORMAL
Cognitive Function and/or Manual Dexterity
Optimal
>60 L/min for low to medium-high resistance DPIs
>30 L/min for high-resistance DPIs
Suboptimal <60 L/min for low to medium-high resistance DPIs
<30 L/min for high-resistance DPIs
Impaired
Cognitive: Dementia, intellectual disabilities, memory loss, trouble completing tasks, and/or difficulty following instructions
Manual: Impaired fine motor activities, tremor, reduced handgrip strength, arthritis
UK
INTERNATIONAL
CHINA
NORDICS
NORDICS
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life
• Oscillating PEP therapy is recommended in the GOLD Report 2025
Nebulised saline (MucoClear) | PARI O-PEP
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
Find out how PARI products can help COPD patients – COPD-PARI
• For patients with congestion, sticky mucus, or mucus plugs, consider. nebulised saline and/or PARI PEP devices.
• Effective mucus management in COPD patients may improve symptoms and quality of life.
Nebulised saline | PARI PEP S System
雾化盐水 | PARI PEP S 系统
了解 PARI 产品如何帮助慢性阻塞性肺病患者 - 慢性阻塞性肺病 - PARI
• 对于有充血、黏稠痰液或黏液栓的患者，考虑使用雾化盐水和/或 PARI PEP 设备。 • 有效的黏液管理可能会改善慢性阻塞性肺病患者的症状和生活质量。
免责声明：治疗设备的选择方案依据国际指南的推荐拟定。 但请注意，本交互式设备选择工具不能取代主治医护人员的专业判断。
将鼠标移动到图表中符合您患者的认知功能和/或手动灵活性以及峰值吸气流速描述的区域，即可为您的患者选择适合的吸入治疗设备。 点击 ⓘ 字段，可以获取相关指导。选定之后，可点击相关设备以获取更多详细信息。
PARI 慢性阻塞性肺病(COPD)吸入装置智选平台
了解 PARI 产品如何帮助慢性阻塞性肺病患者 - 慢性阻塞性肺病 - PARI
• 对于有充血、黏稠痰液或黏液栓的患者，考虑使用雾化盐水和/或 PARI PEP 设备。 • 有效的黏液管理可能会改善慢性阻塞性肺病患者的症状和生活质量。
雾化盐水 | PARI PEP S 系统
了解 PARI 产品如何帮助慢性阻塞性肺病患者 - 慢性阻塞性肺病 - PARI
• 对于有充血、黏稠痰液或黏液栓的患者，考虑使用雾化盐水和/或 PARI PEP 设备。 • 有效的黏液管理可能会改善慢性阻塞性肺病患者的症状和生活质量。
雾化盐水 | PARI PEP S 系统
pMDI：适用于认知能力及手部操作能力正常的患者。应指导患者：“缓慢平稳地吸入。”更多信息请查阅制造商说明书。
优点：可提供多种药物及药物组合，便携，通常可报销。 缺点：要求患者高度协调性，碳足迹相对较高。
pMDI：适用于认知能力及手部操作能力正常的患者。应指导患者：“缓慢平稳地吸入。”更多信息请查阅制造商说明书。
优点：可提供多种药物及药物组合，便携，通常可报销。 缺点：要求患者高度协调性，碳足迹相对较高。
DPI：适用于认知能力及手部操作能力正常且峰值吸气流速(PIF)达标的患者。患者操作指导应为：“用力快速吸气”。 更多信息请查阅制造商说明书。
优点：可使用多种药物及药物组合，设备便携，通常可报销。 缺点：患者需具备较高吸气流速才能分散药物。部分慢性阻塞性肺病患者的峰值吸气流速无法达标。
SMI：适用于认知和手部功能正常的患者，应指导患者“缓慢平稳地吸气”。更多信息请查阅制造商说明。 优点：便携，通常可报销。 缺点：本装置无法使用吸入性糖皮质激素。
SMI：适用于认知和手部功能正常的患者，应指导患者“缓慢平稳地吸气”。更多信息请查阅制造商说明。 优点：便携，通常可报销。 缺点：本装置无法使用吸入性糖皮质激素。
了解PARI产品如何帮助COPD患者 - PARI
• 根据《GOLD 2025报告》，若患者无法正确使用定量吸入器（pMDI），则建议采用单向阀储雾罐 。
• 对于手部与呼吸协调能力差的患者，以及使用含糖皮质激素pMDI的患者，应考虑采用单向阀储雾罐。
• 优点： 可减少声音嘶哑，降低药物在口咽部的沉积。
• 缺点： 与单独使用pMDI相比，体积更大，维护要求更高。
了解PARI产品如何帮助COPD患者 - PARI
• 根据《GOLD 2025报告》，若患者无法正确使用定量吸入器（pMDI），则建议采用单向阀储雾罐 。
• 对于手部与呼吸协调能力差的患者，以及使用含糖皮质激素pMDI的患者，应考虑采用单向阀储雾罐。
• 优点： 可减少声音嘶哑，降低药物在口咽部的沉积。
• 缺点： 与单独使用pMDI相比，体积更大，维护要求更高。
了解PARI产品如何帮助COPD患者 - PARI
了解PARI产品如何帮助COPD患者 - PARI
•急性加重慢性阻塞性肺病(AECOPD)且峰值吸气流速未达标 (sPIF)的患者可从雾化治疗中获益 • 根据《GOLD 2025报告》，若患者无法正确使用定量吸入器（带或不带储雾罐）、干粉吸入器或软雾吸入器，或患者更倾向于使用雾化器而非其他手持设备，应考虑采用雾化治疗 • 长效 β2 受体激动剂 (LABA)、长效毒蕈碱拮抗剂 (LAMA)、吸入性糖皮质激素 (ICS）或双磷酸二酯酶抑制剂（PDE3/PDE4）溶液可用时，应考虑维持性雾化治疗。
了解PARI产品如何帮助COPD患者 - PARI
•急性加重慢性阻塞性肺病(AECOPD)且峰值吸气流速未达标 (sPIF)的患者可从雾化治疗中获益 • 根据《GOLD 2025报告》，若患者无法正确使用定量吸入器（带或不带储雾罐）、干粉吸入器或软雾吸入器，或患者更倾向于使用雾化器而非其他手持设备，应考虑采用雾化治疗 • 长效 β2 受体激动剂 (LABA)、长效毒蕈碱拮抗剂 (LAMA)、吸入性糖皮质激素 (ICS）或双磷酸二酯酶抑制剂（PDE3/PDE4）溶液可用时，应考虑维持性雾化治疗。
了解PARI产品如何帮助COPD患者 - PARI
•急性加重慢性阻塞性肺病(AECOPD)且峰值吸气流速未达标 (sPIF)的患者可从雾化治疗中获益 • 根据《GOLD 2025报告》，若患者无法正确使用定量吸入器（带或不带储雾罐）、干粉吸入器或软雾吸入器，或患者更倾向于使用雾化器而非其他手持设备，应考虑采用雾化治疗 • 长效 β2 受体激动剂 (LABA)、长效毒蕈碱拮抗剂 (LAMA)、吸入性糖皮质激素 (ICS）或双磷酸二酯酶抑制剂（PDE3/PDE4）溶液可用时，应考虑维持性雾化治疗。